Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMost people feel fine on their first Wegovy injection. Some notice mild nausea, tiredness or a dull headache within a few hours of that initial 0.25mg dose — semaglutide first day side effects are real, but they are typically brief and manageable. These are prescription-only medicines, and a prescriber will assess your individual situation before treatment starts. If you are weighing up whether the first day is the hardest part, or wondering what normal looks like versus something worth worrying about, the answer to both is below.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Starting any new medicine carries a degree of uncertainty, and it is completely reasonable to feel apprehensive before that first injection. The good news is that the 0.25mg starting dose exists precisely because the body needs time to adapt to semaglutide's effect on gastric emptying and appetite signalling. That first pen is not a therapeutic dose; it is an adjustment phase, designed to keep early reactions as mild as possible.
The most commonly reported Wegovy side effects (nausea, loose stools, indigestion and mild headache) are largely the result of the gut slowing down more than it is used to. On day one, this usually means a few uncomfortable hours rather than a debilitating day. Nausea tends to arrive two to four hours after the injection and, for most people, has largely settled by the following morning. If you want a closer look at what semaglutide day one side effects typically involve, including their timing and intensity, that detail can help you feel more prepared before you inject. Fatigue and a mild headache are also reported on first days, likely connected to reduced food intake and the body recalibrating.
Eating a small, low-fat meal before injecting, staying well hydrated and avoiding alcohol on injection day are practical steps the NHS semaglutide guidance consistently highlights. None of these eliminates side effects entirely, but they tend to reduce their intensity. The first day is rarely the worst day, many people find subsequent dose increases prompt a brief repeat of similar feelings, which is worth knowing ahead of time.
This is the real question most people face on day one. A mild, passing nausea is expected and does not mean Wegovy is wrong for you. Stopping unnecessarily means missing the clinical benefit that builds over weeks of treatment. At the same time, side effects that are severe, that persist well beyond the first 24 hours, or that feel qualitatively different from ordinary nausea deserve medical attention, not reassurance-seeking from a forum.
The practical test is: are symptoms settling, or are they worsening? If you want to understand what to expect from Wegovy on day one, including which reactions are normal and which are not, that detail can help you judge whether your experience fits the expected pattern. Vomiting that continues into the following day, an inability to keep fluids down, or stomach pain that is sharp and spreading are not in that category. What happens across the first week on Wegovy can help you calibrate whether what you are experiencing fits the expected pattern as titration continues.
Injection-site reactions (a small red mark, brief stinging, minor bruising) are common on day one and do not typically warrant stopping. Rotating between the abdomen, thigh and upper arm across injections helps to reduce this over time. Your Patient Information Leaflet (PIL) and prescriber are the right sources for personalised advice on managing any specific symptom; our FAQs cover many of the most common questions our clinical team receives.
Some side effects of semaglutide require prompt medical attention, and it is important to know them before you inject. In January 2026, the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known, infrequent but serious risk with GLP-1 medicines. The warning signs are severe and persistent stomach pain (often reaching through to the back) sometimes accompanied by vomiting. This is not ordinary nausea. If it happens, seek urgent medical help the same day; do not manage it at home and do not wait for it to pass on its own.
Other symptoms that need prompt attention include: signs of an allergic reaction (swelling of the face or throat, difficulty breathing, rapid heartbeat); symptoms of severe dehydration following prolonged vomiting or diarrhoea (dizziness, very dark urine, inability to drink); and, for people with diabetes, signs of low blood sugar if Wegovy is being used alongside other diabetes medicines. Reading about how side effects can shift on day two of Wegovy outlines how these signals may evolve in the hours after your first injection.
The MHRA's Yellow Card scheme exists for a reason. If you experience a side effect you did not expect, or one that seems serious, reporting it contributes to the ongoing safety monitoring of these medicines. You can do this online directly, or mention it to your prescriber at your next review. Our clinical team is available seven days a week through aftercare, reach us via the contact page if something is not right.
A prescriber who knows your medical history is better placed to anticipate which side effects you are more likely to notice and to advise accordingly. People with a history of significant acid reflux, for example, may find nausea more pronounced early on; those on certain other medicines may need timing advice. None of this can happen when a medicine is obtained without a clinical assessment.
At nume, a GPhC-registered prescriber reads every consultation the same day, not software, not a template. That review includes discussing your health history, current medicines and any concerns you have about starting treatment, including what the first few days might feel like. If Wegovy, the once-weekly semaglutide injection, is clinically appropriate, your prescription is issued and dispatched for free next-working-day delivery. If questions arise after you start, aftercare is available across seven days. To explore whether Wegovy is suitable for you, check your eligibility through a free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.